Aromatase and cyclooxygenases: Enzymes in breast cancer

Journal of Steroid Biochemistry and Molecular Biology

Volumn 86, Issue 3-5, 2003, Pages 501-507

  Brueggemeier, Robert W ^a   Richards, Jeanette A ^a   Petrel, Trevor A ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Aromatase; Cyclooxygenase 1; Cyclooxygenase 2; PPAR receptors; Prostaglandin E2

Indexed keywords

ANTINEOPLASTIC AGENT; AROMATASE; CARBACYCLIN; CIGLITAZONE; CLOFIBRATE; CYCLIC AMP; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOCHROME P450; EPIDERMAL GROWTH FACTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIRINIXIC ACID; PROSTAGLANDIN E2; PROSTANOID RECEPTOR; TRANSFORMING GROWTH FACTOR; TROGLITAZONE; TUMOR MARKER; UNCLASSIFIED DRUG;

BREAST CARCINOMA; CANCER CELL CULTURE; CONFERENCE PAPER; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INDUCTION; ENZYME REGULATION; HUMAN; HUMAN CELL CULTURE; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

EID: 0242457643     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(03)00380-7     Document Type: Conference Paper

References (53)

1. American Cancer Society, Facts and Figures, 2002.
2. Simpson E.R., Mahendroo M.S., Means G.D., Kilgore M.W., Hinshelwood M.M., Graham-Lorence S., Amarneh B., Ito Y., Fisher C.R., Michael M.D.et al. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr. Rev. 15:1994;342-355.
3. James V.H.T., McNeill J.M., Lai L.C., Newton C.J., Braunsberg H., Ghilchik M., Reed M.J. Aromatase activity in normal breast and breast tumor tissues: in vivo and in vitro studies. Steroids. 50:1987;269-279.
4. Miller W.R., O'Neill J. The importance of local synthesis of estrogen within the breast. Steroids. 50:1987;537-548.
5. Reed M.J., Owen A.M., Lai L.C., Coldham N.G., Ghilchik M.W., Shaikh N.A., James V.H.T. In situ oestrone synthesis in normal breast and breast tumour tissues: effect of treatment with 4-hydroxy-androstenedione. Int. J. Cancer. 44:1989;233-237.
6. Reed M.J. The role of aromatase in breast tumors. Breast Cancer Res. Treat. 30:1994;7-17.
7. Bulun S.E., Price T.M., Mahendroo M.S., Aitken J., Simpson E.R. A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcriptase. J. Clin. Endocrinol. Metab. 77:1993;1622-1628.
8. Dowsett M., Macaulay V., Gledhill J., Ryde C., Nicholls J., Ashworth A., McKinna J.A., Smith I.E. Control of aromatase in breast cancer cells and its importance for tumor growth. J. Steroid Biochem. Mol. Biol. 44:1993;605-609.
9. Miller W.R., Mullen P., Sourdaine P., Watson C., Dixon J.M., Telford J. Regulation of aromatase activity within the breast. J. Steroid Biochem. Mol. Biol. 61:1997;193-202.
10. Reed M.J., Topping L., Coldham N.G., Purohit A., Ghilchik M.W., James V.H.T. Control of aromatase activity in breast cancer cells: the role of cytokines and growth factors. J. Steroid Biochem. Mol. Biol. 44:1993;589-596.
11. Quinn A.L., Burak W.E. Jr., Brueggemeier R.W. Effects of matrix components on aromatase activity in breast stromal cells in culture. J. Steroid Biochem. Mol. Biol. 70:1999;249-256.
12. 2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene. Endocrinology. 137:1996;5739-5742.
13. Zhou C., Zhou D., Esteban J., Murai J., Siiteri P.K., Wilczynski S., Chen S. Aromatase gene expression and its exon I usage in human breast tumors. J. Steroid Biochem. Mol. Biol. 59:1996;163-171.
14. Hughes R., Timmermans P., Schrey M.P. Regulation of arachidonic acid metabolism, aromatase activity, and growth in human breast cancer cells by interleukin-1β and phorbol ester. Int. J. Cancer. 67:1996;684-689.
15. Harris R.E., Namboodiri K.K., Farrar W.B. Nonsteroidal antiinflammatory drugs and breast cancer risk. Epidemiology. 7:1996;203-205.
16. Harris R.E., Robertson F.M., Brueggemeier R.W. Genetic induction and upregulation of cyclooxygenase (COX) and aromatase (CYP19): an extension of the dietary fat hypothesis of breast cancer. Med. Hypotheses. 52:1999;291-292.
17. Brueggemeier R.W., Quinn A.L., Parrett M.L., Joarder F.S., Harris R.E., Robertson F.M. Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens. Cancer Lett. 140:1999;27-35.
18. 1 subtype. J. Biol. Chem. 268:1993;26767-26772.
19. 2 subtype. Mol. Pharmacol. 46:1994;213-220.
20. 3 subtype from human erythroleukaemia cells. Biochem. J. 298:1994;263-267.
21. 2. Biochem. Biophys. Res. Commun. 198:1994;999-1006.
22. 2. Biochem. Biophys. Res. Commun. 197:1993;263-270.
23. 2 subtype. J. Biol. Chem. 269:1994;11873-11877.
24. Coleman R.A., Smith W.L., Narumiya S. VIII International Union of Pharmacology classification of prostanoid receptors: properties, distribution and structure of the receptors and their subtypes. Pharmacol. Rev. 46:1994;205-229.
25. Breyer R.M., Bagdassarian C.K., Myers S.A., Breyer M.D. Prostanoid receptors: subtypes and signaling. Annu. Rev. Pharmacol. Toxicol. 41:2001;661-690.
26. 4 differ in desensitization and sensitivity to the metabolic inactivation of the agonist. Mol. Pharmacol. 50:1996;1031-1037.
27. Brueggemeier R.W., Richards J.A., Joomprabutra S., Bhat A.S., Whetstone J.L. Molecular pharmacology of aromatase and its regulation by endogenous and exogenous agents. J. Steroid Biochem. Mol. Biol. 79:2001;75-84.
28. Miller W.L., Weeks J.R., Lauderdale J.W., Kirton K.T. Biological activities of 17-phenyl-18,19,20-trinor prostaglandins. Prostaglandins. 9:1975;9-18.
29. Dong Y.J., Jones R.L., Wilson N.H. Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analogues. Br. J. Pharmacol. 87:1986;97-107.
30. 2 receptor. Biochemistry. 35:1996;7159-7164.
31. 2 receptor antagonist. Biochem. Pharmacol. 50:1995;1731-1733.
32. Schaaf T.K., Bindra J.S., Eggler J.F., Plattner J.J., Nelson A.J., Johnson M.R., Constantine J.W., Hess H.-J. N-(Methanesulfonyl)-16- phenoxyprostaglandincarboxamides: tissue-selective, uterine stimulants. J. Med. Chem. 24:1981;1353-1359.
33. Richards J.A., Petrel T.A., Brueggemeier R.W. Signaling pathways regulating aromatase and cyclooxygenases in normal and malignant breast cells. J. Steroid Biochem. Mol. Biol. 80:2002;203-212.
34. Lazarow P.B., de Duve C. A fatty acyl-CoA oxidizing system in rat liver peroxisomes enhancement by clofibrate, a hypolipidemic drug. Proc. Natl. Acad. Sci. U.S.A. 73:1976;2043-2046.
35. Latruffe N., Vamecq J. Evolutionary aspects of peroxisomes as cell organelles, and of genes encoding peroxisomal proteins. Biol. Cell. 92:2000;389-395.
36. Hess R., Staubli W., Riess W. Nature of the hepatomegalic effect produced by ethyl-chlorophenoxy-isobutyrate in the rat. Nature. 208:1965;856-858.
37. Svoboda D., Azarnoff D. Response of hepatic microbodies to hypolipidemic agent, ethyl chlorophenoxy-isobutyrate (CPIB). J. Cell Biol. 30:1966;442-450.
38. Latruffe N., Vamecq J. Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism. Biochimie. 79:1997;81-94.
39. Corton J.C., Anderson S.P., Stauber A. Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators. Annu. Rev. Pharmacol. Toxicol. 40:2000;491-518.
40. Lemberger T., Desvergne B., Wahli W. Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology. Annu. Rev. Cell Dev. Biol. 12:1996;335-363.
41. Willson T.M., Lambert M.H., Kliewer S.A. Peroxisome proliferator- activated receptor γ and metabolic disease. Annu. Rev. Biochem. 70:2001;341-367.
42. Kliewer S.A., Umesono K., Noonan D.J., Heyman R.A., Evans R.M. Convergence of 9-cis-retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature. 358:1992;771-774.
43. Palmer C.N., Hsu M.-H., Griffin K.J., Johnson E.F. Novel sequence determinants in peroxisome proliferator signaling. J. Biol. Chem. 270:1995;16114-16121.
44. Varanasi U., Chu R., Huang Q., Castellon R., Yeldani A.V.et al. Identification of a peroxisome proliferator-responsive element upstream of the human peroxisomal fatty acyl coenzyme A oxidase gene. J. Biol. Chem. 271:1996;2147-2155.
45. Miyamoto T., Kaneko A., Kakizawa T., Yajima H., Kamijo K.et al. Inhibition of peroxisome proliferator signaling pathways by thyroid hormone receptor. Competitive binding to the response element. J. Biol. Chem. 272:1997;7752-7758.
46. Frohnert B.I., Hui T.Y., Bernlohr D.A. Identification of a functional peroxisome proliferator-responsive element in the murine fatty acid transport protein gene. J. Biol. Chem. 274:1999;3970-3977.
47. Callejas N.A., Castrillo A., Boscá L., Martín-Sanz P. Inhibition of prostaglandin synthesis up-regulates cyclooxygenase-2 induced by lipopolysaccharide and peroxisomal proliferators. J. Pharmacol. Exp. Ther. 288:1999;1235-1241.
48. Kitamura Y., Shimohama S., Koike H., Kakimura J., Matsuoka Y.et al. Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-γ in Alzheimer's disease brains. Biochem. Biophys. Res. Commun. 254:1999;582-586.
49. Meade E.A., McIntyre T.M., Zimmerman G.A., Prescott S.M. Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells. J. Biol. Chem. 274:1999;8328-8334.
50. Bonazzi A., Mastyugin V., Mieyal P.A., Dunn M.W., Laniado-Schwartzman M. Regulation of cyclooxygenase-2 by hypoxia and peroxisome proliferators in the corneal epithelium. J. Biol. Chem. 275:2000;2837-2844.
51. Cao Y., Prescott S.M. Many actions of cyclooxygenase-2 in cellular dynamics and in cancer. J. Cell. Physiol. 190:2002;279-286.
52. 2 is a ligand for the adipocyte determination factor PPARγ Cell. 83:1995;803-812.
53. 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell. 83:1995;813-819.